Prevalence and Treatment of Familial Hypercholesterolemia in France.

Date publication

juin 2019

Journal

The Canadian journal of cardiology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr MOITRY Marie

Tous les auteurs :
Bérard E, Bongard V, Haas B, Dallongeville J, Moitry M, Cottel D, Ruidavets JB, Ferrières J

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31151710

Résumé

Familial hypercholesterolemia (FH) is known to be underdiagnosed and undertreated. The prevalence of heterozygous FH is estimated to be 1 in 500. Nevertheless, a recent meta-analysis of screening in the general population seems to show that the prevalence of FH is more likely to be 1 in 250.

Référence

Can J Cardiol. 2019 Jun;35(6):744-752